104 related articles for article (PubMed ID: 38756088)
1. Tall cell carcinoma of the breast with reversed polarity - a report of three cases with a review of the literature.
Kajo K; Ducár M; Dzuracký J; Macháleková KK; Vallová M; Biró C; Šebest L; Slamka T; Lohajová RB; Žúbor P
Cesk Patol; 2023; 59(3):132-138. PubMed ID: 38756088
[TBL] [Abstract][Full Text] [Related]
2. Tall cell carcinoma of the breast with reversed polarity (TCCRP) with mutations in the IDH2 and PIK3CA genes: a case report.
Haefliger S; Muenst S; Went P; Bihl M; Dellas S; Weber WP; Vlajnic T
Mol Biol Rep; 2020 Jun; 47(6):4917-4921. PubMed ID: 32474846
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.
Pareja F; da Silva EM; Frosina D; Geyer FC; Lozada JR; Basili T; Da Cruz Paula A; Zhong E; Derakhshan F; D'Alfonso T; Wen HY; Giri DD; Hayes MM; Krings G; Bhargava R; Palazzo JP; Rakha EA; Hoda SA; Sanders ME; Collins LC; Schnitt SJ; Chen YY; Weigelt B; Jungbluth AA; Reis-Filho JS; Brogi E
Mod Pathol; 2020 Jun; 33(6):1056-1064. PubMed ID: 31896809
[TBL] [Abstract][Full Text] [Related]
4. The Diagnostic Utility of IDH2 R172 Immunohistochemistry in Tall Cell Carcinoma With Reversed Polarity of the Breast.
Sasaki E; Iwakoshi A; Satake T; Nakajima K; Kobayashi M; Ando Y; Koshikawa T; Masago K; Honma N; Nishimura R; Kato Y; Ichihara S
Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):654-661. PubMed ID: 36222504
[TBL] [Abstract][Full Text] [Related]
5. Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.
Lozada JR; Basili T; Pareja F; Alemar B; Paula ADC; Gularte-Merida R; Giri DD; Querzoli P; Cserni G; Rakha EA; Foschini MP; Reis-Filho JS; Brogi E; Weigelt B; Geyer FC
Histopathology; 2018 Aug; 73(2):339-344. PubMed ID: 29603332
[TBL] [Abstract][Full Text] [Related]
6. Tall Cell Carcinoma with Reversed Polarity: Case Report of a Rare Special Type of Breast Cancer and Review of the Literature.
Elghobashy M; Jenkins S; Shulman Z; O'Neil A; Kouneli S; Shaaban AM
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760817
[No Abstract] [Full Text] [Related]
7. Case report: Tall cell carcinoma with reversed polarity of the breast: an additional case and review of the literature.
Lei Z; Wang YX; Wang ZY; Yang CG; Pan GQ
Front Oncol; 2024; 14():1302196. PubMed ID: 38434689
[TBL] [Abstract][Full Text] [Related]
8. Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases.
Alsadoun N; MacGrogan G; Truntzer C; Lacroix-Triki M; Bedgedjian I; Koeb MH; El Alam E; Medioni D; Parent M; Wuithier P; Robert I; Boidot R; Arnould L
Mod Pathol; 2018 Sep; 31(9):1367-1380. PubMed ID: 29785016
[TBL] [Abstract][Full Text] [Related]
9. Tall cell carcinoma with reversed polarity: case report with gene sequencing and literature review.
Wei Y; Ding L; Song X; Tian X; Min N; Guan Q; Li X; Liu M
Gland Surg; 2021 Nov; 10(11):3147-3154. PubMed ID: 34926230
[TBL] [Abstract][Full Text] [Related]
10. Tall Cell Carcinoma with Reverse Polarity of Breast: Report of a Case with Unique Morphologic and Molecular Features.
Jassim M; Premalata CS; Okaly G; Srinivas C
Turk Patoloji Derg; 2021; 37(2):183-188. PubMed ID: 33021737
[TBL] [Abstract][Full Text] [Related]
11. Imprint Cytology of Tall Cell Carcinoma with Reversed Polarity of the Breast: A Case Report.
Shinomiya Y; Kouchi Y; Onodera K; Yamamoto H; Harada-Kagitani S; Sakakibara J; Nagashima T; Ikeda JI; Kishimoto T
Acta Cytol; 2024; 68(1):73-79. PubMed ID: 38262369
[TBL] [Abstract][Full Text] [Related]
12. Tall cell carcinoma of the breast with reverse polarity: case report with gene sequencing and literature review.
Zhang X; Wu H; Wang Z; Zhou Y; Mao F; Lin Y; Shen S; Liang Z; Sun Q
Gland Surg; 2021 Feb; 10(2):837-843. PubMed ID: 33708566
[TBL] [Abstract][Full Text] [Related]
13. Breast Tumor Resembling the Tall Cell Variant of Papillary Thyroid Carcinoma: Molecular Characterization by Next-Generation Sequencing and Histopathological Comparison With Tall Cell Papillary Carcinoma of Thyroid.
Zhong E; Scognamiglio T; D'Alfonso T; Song W; Tran H; Baek I; Hoda SA
Int J Surg Pathol; 2019 Apr; 27(2):134-141. PubMed ID: 30227763
[TBL] [Abstract][Full Text] [Related]
14. Tall cell carcinoma with reversed polarity of breast: Sonographic and magnetic resonance imaging findings.
Lee NY; Chang YW; Lee EJ; Jin YM
J Clin Ultrasound; 2023 Mar; 51(3):494-497. PubMed ID: 35904337
[TBL] [Abstract][Full Text] [Related]
15. Breast Tumor Resembling Tall Cell Variant of Papillary Thyroid Carcinoma: A Solid Papillary Neoplasm With Characteristic Immunohistochemical Profile and Few Recurrent Mutations.
Bhargava R; Florea AV; Pelmus M; Jones MW; Bonaventura M; Wald A; Nikiforova M
Am J Clin Pathol; 2017 Apr; 147(4):399-410. PubMed ID: 28375433
[TBL] [Abstract][Full Text] [Related]
16. Tall cell carcinoma with reversed polarity: A case report of a very rare breast tumor entity and mini-review.
Trihia HJ; Lampropoulos P; Karelis L; Souka E; Galanopoulos G; Provatas I
Breast J; 2021 Apr; 27(4):369-376. PubMed ID: 33527653
[TBL] [Abstract][Full Text] [Related]
17. IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
Chiang S; Weigelt B; Wen HC; Pareja F; Raghavendra A; Martelotto LG; Burke KA; Basili T; Li A; Geyer FC; Piscuoglio S; Ng CK; Jungbluth AA; Balss J; Pusch S; Baker GM; Cole KS; von Deimling A; Batten JM; Marotti JD; Soh HC; McCalip BL; Serrano J; Lim RS; Siziopikou KP; Lu S; Liu X; Hammour T; Brogi E; Snuderl M; Iafrate AJ; Reis-Filho JS; Schnitt SJ
Cancer Res; 2016 Dec; 76(24):7118-7129. PubMed ID: 27913435
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
[TBL] [Abstract][Full Text] [Related]
19. GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.
Yang Y; Lu S; Zeng W; Xie S; Xiao S
Ann Diagn Pathol; 2017 Feb; 26():1-5. PubMed ID: 28038704
[TBL] [Abstract][Full Text] [Related]
20. The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
Sangoi AR; Shrestha B; Yang G; Mego O; Beck AH
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):229-37. PubMed ID: 25906123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
